• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传因素在川崎病中的作用:遗传关联研究的系统评价与荟萃分析

The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies.

作者信息

Xie Xiaochuan, Shi Xiaohan, Liu Meilin

机构信息

Department of Geriatrics, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing, 100034, China.

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.

出版信息

Pediatr Cardiol. 2018 Feb;39(2):207-225. doi: 10.1007/s00246-017-1760-0. Epub 2017 Nov 2.

DOI:10.1007/s00246-017-1760-0
PMID:29098351
Abstract

This systematic review and meta-analysis aimed to better elucidate the roles of genetic factors in Kawasaki disease (KD), and determine the potential genetic biomarkers of KD. The systematic literature search of PubMed, Medline, Embase, Web of Science and CNKI identified 164 eligible studies. The qualitative synthesis revealed that 62 genes may be correlated with the susceptibility to KD, and 47 genes may be associated with the incidence of coronary artery lesions (CALs) in KD. A total of 53 polymorphisms in 34 genes were investigated in further quantitative synthesis. Of these, 23 gene polymorphisms were found to be significantly correlated with KD susceptibility, and 10 gene polymorphisms were found to be significantly associated with the incidence of CALs in KD. In conclusion, our findings indicate that gene polymorphisms of ACE, BLK, CASP3, CD40, FCGR2A, FGβ, HLA-E, IL1A, IL6, ITPKC, LTA, MPO, PD1, SMAD3, CCL17 and TNF may affect KD susceptibility. Besides, genetic variations in BTNL2, CASP3, FCGR2A, FGF23, FGβ, GRIN3A, HLA-E, IL10, ITPKC and TGFBR2 may serve as biomarkers of CALs in KD.

摘要

本系统评价和荟萃分析旨在更好地阐明遗传因素在川崎病(KD)中的作用,并确定KD的潜在遗传生物标志物。通过对PubMed、Medline、Embase、Web of Science和中国知网进行系统的文献检索,共识别出164项符合条件的研究。定性综合分析显示,62个基因可能与KD易感性相关,47个基因可能与KD冠状动脉病变(CALs)的发生有关。在进一步的定量综合分析中,对34个基因中的53个多态性进行了研究。其中,发现23个基因多态性与KD易感性显著相关,10个基因多态性与KD中CALs的发生显著相关。总之,我们的研究结果表明,ACE、BLK、CASP3、CD40、FCGR2A、FGβ、HLA-E、IL1A、IL6、ITPKC、LTA、MPO、PD1、SMAD3、CCL17和TNF的基因多态性可能影响KD易感性。此外,BTNL2、CASP3、FCGR2A、FGF23、FGβ、GRIN3A、HLA-E、IL10、ITPKC和TGFBR2的基因变异可能作为KD中CALs的生物标志物。

相似文献

1
The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies.遗传因素在川崎病中的作用:遗传关联研究的系统评价与荟萃分析
Pediatr Cardiol. 2018 Feb;39(2):207-225. doi: 10.1007/s00246-017-1760-0. Epub 2017 Nov 2.
2
Neutrophil to Lymphocyte Ratio as a Biomarker for Predicting the Coronary Artery Abnormality in Kawasaki Disease: A Meta-Analysis.中性粒细胞与淋巴细胞比值作为川崎病冠状动脉异常预测生物标志物的Meta 分析。
Dis Markers. 2022 Oct 11;2022:6421543. doi: 10.1155/2022/6421543. eCollection 2022.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Corticosteroids for the treatment of Kawasaki disease in children.皮质类固醇治疗儿童川崎病。
Cochrane Database Syst Rev. 2022 May 27;5(5):CD011188. doi: 10.1002/14651858.CD011188.pub3.
5
The roles of endothelial nitric oxide synthase gene polymorphisms in diabetes mellitus and its associated vascular complications: a systematic review and meta-analysis.内皮型一氧化氮合酶基因多态性在糖尿病及其相关血管并发症中的作用:系统评价和荟萃分析。
Endocrine. 2018 Nov;62(2):412-422. doi: 10.1007/s12020-018-1683-4. Epub 2018 Aug 23.
6
The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects.PAI-1 基因多态性在动脉粥样硬化疾病中的作用:一项涉及 149908 例受试者的系统评价和荟萃分析。
Gene. 2018 Oct 5;673:167-173. doi: 10.1016/j.gene.2018.06.040. Epub 2018 Jun 22.
7
MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring.川崎病相关 microRNAs:诊断、治疗和监测的新进展。
Front Immunol. 2022 Oct 24;13:1016575. doi: 10.3389/fimmu.2022.1016575. eCollection 2022.
8
Infliximab as a second-line therapy for children with refractory Kawasaki disease: A systematic review and meta-analysis of randomized controlled trials.英夫利昔单抗作为难治性川崎病患儿二线治疗的疗效:一项随机对照试验的系统评价和荟萃分析。
Br J Clin Pharmacol. 2023 Jan;89(1):49-60. doi: 10.1111/bcp.15547. Epub 2022 Oct 19.
9
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素:定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
Integrative machine learning and Mendelian randomization identify causal laboratory biomarkers for coronary artery lesions in Kawasaki disease: a prospective study.整合机器学习与孟德尔随机化方法确定川崎病冠状动脉病变的因果实验室生物标志物:一项前瞻性研究。
Front Genet. 2025 Aug 15;16:1646032. doi: 10.3389/fgene.2025.1646032. eCollection 2025.
2
Recent advances in research on gene polymorphisms in Kawasaki disease.川崎病基因多态性的研究新进展
World J Clin Pediatr. 2025 Sep 9;14(3):106693. doi: 10.5409/wjcp.v14.i3.106693.
3
Single Nucleotide Polymorphisms and Their Association with Coronary Artery Aneurysms and IVIG Resistance in Kawasaki Disease in Ireland.

本文引用的文献

1
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease.静脉注射免疫球蛋白治疗川崎病
Pediatr Ann. 2017 Jan 1;46(1):e25-e28. doi: 10.3928/19382359-20161212-01.
2
Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.在硬皮病小鼠模型中,转化生长因子-β在调节血管重塑、炎症和肺纤维化方面发挥着不同作用。
Am J Physiol Lung Cell Mol Physiol. 2017 Jan 1;312(1):L22-L31. doi: 10.1152/ajplung.00428.2016. Epub 2016 Nov 18.
3
Kawasaki Disease.
单核苷酸多态性及其与爱尔兰川崎病冠状动脉瘤和静脉注射免疫球蛋白抵抗的关联。
Pediatr Cardiol. 2025 Aug 8. doi: 10.1007/s00246-025-03989-0.
4
FCGR2A Gene Polymorphism Association in Children with Multisystem Inflammatory Syndrome.多系统炎症综合征患儿中FCGR2A基因多态性关联研究
Indian Pediatr. 2025 May;62(5):372-377. doi: 10.1007/s13312-025-00047-z. Epub 2025 Apr 11.
5
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
6
Platelet-Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease.血小板-单核细胞聚集体引发川崎病中的炎症和血管病变。
Adv Sci (Weinh). 2025 Feb;12(5):e2406282. doi: 10.1002/advs.202406282. Epub 2024 Dec 12.
7
Accuracy of Machine Learning in Discriminating Kawasaki Disease and Other Febrile Illnesses: Systematic Review and Meta-Analysis.机器学习在鉴别川崎病和其他发热性疾病中的准确性:系统评价和荟萃分析。
J Med Internet Res. 2024 Nov 18;26:e57641. doi: 10.2196/57641.
8
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
9
gene polymorphism and its expression in children with Kawasaki disease from North India: a preliminary case-control study and meta-analysis.印度北部川崎病患儿的基因多态性及其表达:一项初步病例对照研究和荟萃分析。
Front Pediatr. 2023 Sep 21;11:1252024. doi: 10.3389/fped.2023.1252024. eCollection 2023.
10
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID.儿童多系统炎症综合征(MIS-C):与长新冠的关联。
Inflammopharmacology. 2023 Oct;31(5):2221-2236. doi: 10.1007/s10787-023-01272-3. Epub 2023 Jul 17.
川崎病。
J Am Coll Cardiol. 2016 Apr 12;67(14):1738-49. doi: 10.1016/j.jacc.2015.12.073.
4
Recent Advances in Kawasaki Disease.川崎病的最新进展
Yonsei Med J. 2016 Jan;57(1):15-21. doi: 10.3349/ymj.2016.57.1.15.
5
T-Helper Cytokine Profiles in Patients with Kawasaki Disease.川崎病患者的辅助性T细胞细胞因子谱
Korean Circ J. 2015 Nov;45(6):516-21. doi: 10.4070/kcj.2015.45.6.516. Epub 2015 Nov 25.
6
Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.关于免疫受体酪氨酸抑制基序(ITIMs)、免疫受体酪氨酸激活基序(ITAMs)以及免疫受体酪氨酸激活基序类似物(ITAMis):重新审视免疫球蛋白Fc受体信号传导
Immunol Rev. 2015 Nov;268(1):66-73. doi: 10.1111/imr.12336.
7
Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.阿托伐他汀和西地那非可降低血管紧张素转化酶 -β水平和基质金属蛋白酶 -2活性,并改善肾血管性高血压模型中的动脉重塑。
Redox Biol. 2015 Dec;6:386-395. doi: 10.1016/j.redox.2015.08.017. Epub 2015 Aug 31.
8
[Association of single nucleotide polymorphisms in TARC/CCL17 gene with Kawasaki disease and its clinical characteristics].[TARC/CCL17基因单核苷酸多态性与川崎病及其临床特征的关联]
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Jul;17(7):668-71.
9
Kawasaki disease: insights into pathogenesis and approaches to treatment.川崎病:发病机制的深入了解和治疗方法。
Nat Rev Rheumatol. 2015 Aug;11(8):475-82. doi: 10.1038/nrrheum.2015.54. Epub 2015 Apr 28.
10
Kawasaki disease: an evolving paradigm.川崎病:一个不断发展的范式。
Autoimmun Rev. 2015 Aug;14(8):703-9. doi: 10.1016/j.autrev.2015.04.002. Epub 2015 Apr 13.